D007632Chemicals & DrugsD09.698.373.550460.991231Keratan SulfateFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonMichaelCharltonMichael Charlton0.000000000000000.000000000000003423Charlton, MichaelProfessor23007134Krishnan A, Li X, Kao WY, Viker K, Butters K, Masuoka H, Knudsen B, Gores G, Charlton MLaboratory investigation; a journal of technical methods and pathologyLumican, an extracellular matrix proteoglycan, is a novel requisite for hepatic fibrosis. Lab Invest. 2012 Dec; 92(12):1712-25.Lab Invest2012-09-24T00:00:002012Lumican, an extracellular matrix proteoglycan, is a novel requisite for hepatic fibrosis.19330863Charlton M, Viker K, Krishnan A, Sanderson S, Veldt B, Kaalsbeek AJ, Kendrick M, Thompson G, Que F, Swain J, Sarr MHepatology (Baltimore, Md.)Differential expression of lumican and fatty acid binding protein-1: new insights into the histologic spectrum of nonalcoholic fatty liver disease. Hepatology. 2009 Apr; 49(4):1375-84.Hepatology2009-04-01T00:00:002009Differential expression of lumican and fatty acid binding protein-1: new insights into the histologic spectrum of nonalcoholic fatty liver disease.Pediatrics-Kennedy CenterMedicine-Gastroenterology0.798820.2279134research area of0.5072160.01660646subject area for9602619Liu NP, Baldwin J, Lennon F, Stajich JM, Thonar EJ, Pericak-Vance MA, Klintworth GK, Vance JMThe British journal of ophthalmologyCoexistence of macular corneal dystrophy types I and II in a single sibship. Br J Ophthalmol. 1998 Mar; 82(3):241-4.Br J Ophthalmol1998-03-01T00:00:001998Coexistence of macular corneal dystrophy types I and II in a single sibship.36255674Schwartz NB, Domowicz MSAdvances in neurobiologyChemistry and Function of Glycosaminoglycans in the Nervous System. Adv Neurobiol. 2023; 29:117-162.Adv Neurobiol2023-01-01T00:00:002023Chemistry and Function of Glycosaminoglycans in the Nervous System.PediatricsSurgeryUniversity of ChicagoNancy B.SchwartzNancy B. Schwartz41.78927490000000-87.601250000000001432Schwartz, Nancy B.ProfessorMiriamDomowiczMiriam Domowicz41.78927490000000-87.601250000000001627Domowicz, MiriamResearch Associate Professortrue1ProfessorProfessortrue1ProfessorProfessortrue1Research Associate ProfessorResearch Associate Professortrue1Clinical AssociateClinical Associate101024744179Nelson EG, Hinojosa RJAMA otolaryngology-- head & neck surgeryAnalysis of the Hyalinization Reaction in Otosclerosis. JAMA Otolaryngol Head Neck Surg. 2014 Jun; 140(6):555-9.JAMA Otolaryngol Head Neck Surg2014-06-01T00:00:002014Analysis of the Hyalinization Reaction in Otosclerosis.ErikNelsonErik Nelson0.000000000000000.000000000000002783Nelson, ErikClinical Associate